CEO Jerry McLaughlin will present at the Neuroscience BioPartnering & Investment Forum on Tuesday, February 23, at 3:35 pm Eastern Time. The BIO CEO & Investor Conference is being held at The New York Academy of Sciences.
Baltimore, MD, February 17, 2016 — AgeneBio, a biopharmaceutical company developing innovative therapeutics for unserved patients battling neurodegeneration, today announced the company will present at the Neuroscience BioPartnering & Investment Forum. CEO Jerry McLaughlin will present a overview of AgeneBio‘s work in neurodegeneration and its upcoming HOPE4MCI Phase 3 Trial on February 23 at 3:35 pm Eastern Time. The Neuroscience…
CEO Jerry McLaughlin will present in the CNS/Neurological Track on Monday, February 8, at 10:15 am Eastern Time. The BIO CEO & Investor Conference is being held February 8 and 9 at the Waldorf Astoria New York.
Baltimore, MD, February 2, 2016 — AgeneBio, a biopharmaceutical company developing innovative therapeutics for unserved patients battling neurodegeneration, today announced the company will present at BIO CEO & Investor Conference. CEO Jerry McLaughlin will present in the CNS/Neurological Track on Monday, February 8, at 10:15 am Eastern Time. The BIO CEO & Investor Conference is being held February 8 and…